Navigation Links
InVitria's Cellastim Delivers Superior Results in Mammalian Cell Culture
Date:9/25/2008

FORT COLLINS, Colo., Sept. 25 /PRNewswire/ -- Steve Pettit, Director of the company's Cell Culture Group, presented results of InVitria's (http://www.InVitria.com) Cellastim in mammalian cell culture at the 2008 BioProcess International Conference in Anaheim, California this week.

"Cellastim showed superior results compared to other sources of albumin and delivered an average of 50% improvement in productivity in CHO cell lines using variety of the leading chemically defined and animal free medias sold in the US," said Dr. Steve Pettit, Director of InVitria's Cell Culture Group.

Studies support InVitria's claim that its Cellastim product, an animal free recombinant human serum albumin, outperforms other chemically defined cell culture ingredients and is gaining acceptance by the biopharmaceutical industry as a supplement for cell culture media. Cellastim is a defined supplement that can enhance performance of chemically-defined media.

Additionally, InVitria's Lacromin product, which is an animal free recombinant lactoferrin, has proven to be a strong growth factor while simultaneously enhancing productivity across many cell lines.

"We continue to show powerful results of Cellastim and Lacromin in cell culture media for a variety of cell lines including CHO, Hybridoma, Vero and NS0 cells. Since these are well defined supplements, they help our customers achieve both their regulatory and manufacturing goals. These are the only supplements available that not only improve cell culture performance, but do this while maintaining a defined and animal free media," said Scott Deeter, InVitria's President.

To obtain a copy of Dr. Pettit's presentation please contact InVitria by phone or email at:
1-800-916-8311

info@InVitria.com

About InVitria (http://www.InVitria.com)

InVitria has developed animal free cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
2. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
3. Core Informatics Delivers Enterprise Core LIMS Installation to BioRelix Pharmaceuticals
4. NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
5. Millennium Over-Delivers on 2007 Goals and Financial Guidance
6. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
7. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
8. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
9. Increasing Sales Productivity Through Superior Sales Force Performance Management
10. By adding graphene, researchers create superior polymer
11. Flurizans Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimers Disease is Superior to That of Aricept
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... 2017  Kinexum, a distinguished resource for research, development ... appointment of Thomas C. Seoh as President ... Kinexum founder, who becomes Executive Chairman and will continue ... Thomas Seoh commented, "I am ... and lead the firm,s remarkable team of life science ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... teamed up with NASA to showcase the future of deep space exploration and ... (SLS) rocket and Orion spacecraft and includes a guest appearance by former Shuttle ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced ... added to its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme ... only able to offer NAT screening for blood donors under an Investigational New Drug ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... EMEA and North America this May on the following ... , Donald H. Taylor, Chairman of the Learning and Performance Institute will be ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
Breaking Biology News(10 mins):